文献速递外周动脉疾病

膝下腔内与开放血运重建治疗致残性跛行的长期耐久性

Long-term Durability of Infrainguinal Endovascular and Open Revascularization for Disabling Claudication.
PubMed 文献 · Ann Vasc Surg · 2018-05-15

研究纳入194例致残性跛行(Rutherford 3级)患者,比较开放大隐静脉、开放人工血管、腔内TASC II A/B与C/D四组的通畅率与临床成功率。中位随访57±33个月,5年一期通畅率与一期临床成功率各组间有差异,TASC II C/D病变再干预率较高。

要点

  • 5年一期通畅率:开放大隐静脉58%、开放人工血管40%、腔内A/B 72%、腔内C/D 38%(P<0.001)。
  • 5年一期临床成功率:开放大隐静脉46%、开放人工血管40%、腔内A/B 57%、腔内C/D 44%(P=0.02)。
  • 腔内C/D组再干预率36%,其中近20%最终需开放旁路手术。

核心结论

  • 膝下血运重建治疗跛行的耐久性主要取决于病变的解剖复杂程度。
  • 开放与腔内干预均可获得较好的长期临床成功,但再干预率较高,尤其在TASC II C和D病变患者中。
  • 相当一部分腔内治疗患者最终需开放手术血运重建以维持临床获益。
  • 本研究中近20%因TASC II C和D病变接受腔内治疗的患者最终需开放旁路手术。

研究设计与样本

  • 回顾性分组比较194例致残性跛行(Rutherford 3级)患者,接受开放(n=53)或腔内(n=141)干预。
  • 分为开放-大隐静脉(n=21)、开放-人工血管(n=32)、腔内-TASC II A和B(n=48)、腔内-TASC II C和D(n=93)四组。

主要发现

  • 平均随访57±33个月,5年一期通畅率:开放-大隐静脉58%、开放-人工血管40%、腔内-A/B 72%、腔内-C/D 38%(P<0.001)。
  • 5年二期通畅率:开放-大隐静脉77%、开放-人工血管50%、腔内-A/B 96%、腔内-C/D 61%(P<0.001)。
  • 免于主要不良肢体事件率:开放-大隐静脉73%、腔内-A/B 77%、腔内-C/D 70%、开放-人工血管67%(P=0.279)。
  • 5年一期临床成功率:开放-大隐静脉46%、开放-人工血管40%、腔内-A/B 57%、腔内-C/D 44%(P=0.02)。
  • 5年二期临床成功率:开放-大隐静脉78%、开放-人工血管78%、腔内-A/B 85%、腔内-C/D 84%(P=0.732)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infrainguinal revascularization for disabling claudication (DC) is frequently performed, but long-term results are still unknown. In this study, we compared clinical outcomes of infrainguinal endovascular (EV) and open interventions for DC after the failure of medical management. METHODS: One hundred ninety-four patients with DC (Rutherford category 3) who had open (n = 53) or EV (n = 141) interventions were grouped as open-great saphenous vein (GSV) (n = 21), open-prosthetic (n = 32), EV-Trans-Atlantic Inter-Society Consensus II (TASC II) A and B (AB) (n = 48), and EV-TASC II C and D (CD) (n = 93). Patency, primary clinical success (PCS; sustained improvement in symptoms without reintervention), and secondary clinical success (SCS; sustained improvement in symptoms with reintervention) rates were compared. RESULTS: Mean follow-up was 57 ± 33 months. Five-year primary patency was 58% in open-GSV, 40% in open-prosthetic, 72% in EV-AB, and 38% in EV-CD (P < 0.001). Five-year secondary patency was 77% in open-GSV, 50% in open-prosthetic, 96% in EV-AB, and 61% in EV-CD (P < 0.001). Freedom from major adverse limb events was 73% in open-GSV, 77% in EV-AB, 70% in EV-CD, and 67% in open-prosthetic (P = 0.279). Five-year PCS was 46% in open-GSV, 40% in open-prosthetic, 57% in EV-AB, and 44% in EV-CD (P = 0.02). Five-year SCS was 78% in open-GSV, 78% in open-prosthetic, 85% in EV-AB, and 84% in EV-CD (P = 0.732). A total of 116 reinterventions were performed, 10 in 6 limbs (27%) in open-GSV, 18 in 12 limbs (36%) in open-prosthetic, 26 in 15 limbs (24%) in EV-AB, and 62 in 39 limbs (36%) in EV-CD. Reinterventions included 71 (61%) EV and 45 (39%) open procedures. CONCLUSIONS: Durability of infrainguinal interventions in claudicants depends mainly on anatomic complexity of disease. Good long-term clinical success can be achieved with both open and EV interventions, albeit with high reintervention rates, especially in patients with TASC II C and D disease. A considerable subset of EV patients will eventually require surgical revascularization to maintain clinical benefit. In this study, almost 20% of patients undergoing EV for TASC II C and D disease eventually required surgical bypass.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Khan SZ, Rivero M, Cherr GS, et al. Long-term Durability of Infrainguinal Endovascular and Open Revascularization for Disabling Claudication. Ann Vasc Surg. 2018. PMID: 29772315. doi:10.1016/j.avsg.2018.02.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。